180 Life Sciences Granted Extension by Nasdaq Hearing Panel to Regain Compliance With Continued Listing Requirements
納斯達克聽證會審批180 life sciences延期符合繼續上市要求
180 Life Sciences Granted Extension by Nasdaq Hearing Panel to Regain Compliance With Continued Listing Requirements
納斯達克聽證會審批180 life sciences延期符合繼續上市要求
譯文內容由第三人軟體翻譯。